In a mouse B-cell lymphoma model, they showed that combining L-asparaginase with phenformin, an electron transferring chain (ETC) inhibitor that depletes intracellular aspartate, an indispensable precursor for asparagine, significantly reduced c-MYC expression and lymphoma burden [61]. Here, MYC is linked to lymphoma.